Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

World's Biggest Sovereign Wealth Fund Cashes Out Of Rivian, Trims Tesla Stake, But Bulks Up On This Chinese EV Maker

Norges Bank, the central bank of Norway and the sponsor of the world's biggest sovereign wealth fund (the Norwegian Oil Fund), has substantially changed its allocation toward electric vehicle stocks in the first quarter.

Krispy Kreme Shares Gain On Solid Q1 Performance

Krispy Kreme Shares Gain On Solid Q1 Performance

Krispy Kreme Inc (NASDAQ:DNUT) reported first-quarter FY21 sales growth of 15.8% year-on-year to $372.5 million, beating the consensus of $367.9 million. Organic revenue grew 15%. The company's Q1 growth was driven by the performance and expansion of Krispy Kreme's Omni-channel model and strong performances across all three business segments. Revenue in the U.S.…

What 10 Stocks Are Down More Than 10%?

What 10 Stocks Are Down More Than 10%?

Benzinga’s “10 Stocks Down More Than 10%” aims to deliver investors the news surrounding hot stocks with significant price action for the week beginning May 9, 2022.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Earnings Outlook For Eton Pharmaceuticals

Eton Pharmaceuticals (NASDAQ:ETON) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Eton Pharmaceuticals will report an earnings per share (EPS) of $-0.08.

Brickell Biotech's Earnings Outlook

Brickell Biotech (NASDAQ:BBI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Brickell Biotech will report an earnings per share (EPS) of $-0.06.

Earnings Outlook For Eledon Pharmaceuticals

Eledon Pharmaceuticals (NASDAQ:ELDN) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Eledon Pharmaceuticals will report an earnings per share (EPS) of $-0.68.

ATA Creativity Global's Earnings: A Preview

ATA Creativity Global (NASDAQ:AACG) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that ATA Creativity Global will report an earnings per share (EPS) of $-0.25.

inkl

Read news from The Economist, FT, and more,
with one subscription

Spectrum Pharmaceuticals's Earnings Outlook

Spectrum Pharmaceuticals's Earnings Outlook

Spectrum Pharmaceuticals (NASDAQ:SPPI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Spectrum Pharmaceuticals will report an earnings per share (EPS) of $-0.19.

Sientra's Earnings Outlook

Sientra's Earnings Outlook

Sientra (NASDAQ:SIEN) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Sientra will report an earnings per share (EPS) of $-0.24.

Earnings Outlook For Applied DNA Sciences

Earnings Outlook For Applied DNA Sciences

Applied DNA Sciences (NASDAQ:APDN) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Applied DNA Sciences will report an earnings per share (EPS) of $-0.33.

Where Steel Dynamics Stands With Analysts

Where Steel Dynamics Stands With Analysts

Steel Dynamics (NASDAQ:STLD) has observed the following analyst ratings within the last quarter:

Earnings Preview: Regulus Therapeutics

Earnings Preview: Regulus Therapeutics

Regulus Therapeutics (NASDAQ:RGLS) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Regulus Therapeutics will report an earnings per share (EPS) of $-0.05.

Preview: Processa Pharmaceuticals's Earnings

Preview: Processa Pharmaceuticals's Earnings

Processa Pharmaceuticals (NASDAQ:PCSA) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Processa Pharmaceuticals will report an earnings per share (EPS) of $-0.21.

Earnings Preview For Arcadia Biosciences

Earnings Preview For Arcadia Biosciences

Arcadia Biosciences (NASDAQ:RKDA) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Arcadia Biosciences will report an earnings per share (EPS) of $-0.34.

Get all your
news in one place.

100's of premium titles.
One news app.

What 5 Analyst Ratings Have To Say About Kodiak Sciences

Within the last quarter, Kodiak Sciences (NASDAQ:KOD) has observed the following analyst ratings:

Analyst Ratings for Hydrofarm Holdings Group

Within the last quarter, Hydrofarm Holdings Group (NASDAQ:HYFM) has observed the following analyst ratings:

Insurance Stocks Moving In Wednesday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Olaplex Clocks 58% Top-Line Growth In Q1; Affirms FY22 Forecast

Olaplex Holdings Inc (NASDAQ:OLPX) reported first-quarter FY22 sales growth of 57.6% year-on-year to $186.2 million, beating the consensus of $172.46 million. The gross profit increased 50.9% Y/Y to $141.2 million and the gross margin contracted 340 basis points to 75.8%. Selling, general and administrative expenses increased 97.8% to $22.3 million. The operating margin…

Get all your
news in one place.

100's of premium titles.
One news app.

Norwegian Central Bank Substantially Reduces Stakes In Alibaba And This Chipmaker: Here's What Norges Bought Instead

Amid the ongoing tech rout, Norges Bank made some cosmetic moves on its tech investments, barring a few liquidations and stake builds.

EVgo Q1 Results Miss Street View; Affirms FY22 Outlook

EVgo Inc (NASDAQ:EVGO) reported first-quarter FY22 sales growth of 86% year-on-year to $7.7 million, missing the consensus of $8.73 million. EVgo's network throughput for the quarter was 8.0 Gigawatt-hours (GWh), a 95% Y/Y growth. Adjusted EBITDA loss was $(18.2) million versus $(9.8) million last year. Gross loss for the quarter narrowed to $(0.6)…

Gene Munster Turns Cautious On Tech Stocks, But Not Apple Or Tesla: Here's Why

Loup Ventures' Gene Munster is cautious on the broader technology sector, but there are two big tech names he remains bullish on.

What To Watch On Rivian's Stock Heading Into Q1 Earnings

Rivian Automotive, Inc (NASDAQ: RIVN) was falling over 7% lower on Wednesday as the electric vehicle manufacturer headed into its first-quarter earnings print, which is expected after the market close.

Mid-Day Market Update: Crude Oil Surges 6%; Kornit Digital Shares Plummet

U.S. stocks traded mixed midway through trading, with the Dow Jones jumping more than 100 points on Wednesday.

Redbox Gets Acquired With Bizarre Takeunder Financing: What You Need To Know

DVD rental and streaming company Redbox Entertainment Inc (NASDAQ: RDBX) was the subject of a takeover offer Wednesday, or what some are calling a takeunder offer due to the acquisition price being less than the price of the stock. Here are the details.

Stocks That Hit 52-Week Lows On Wednesday

On Wednesday, 807 companies reached new 52-week lows.

1 … 515 516 517 518

People

Julian Klymochko

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

electric vehicle

Places

364,170 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play